{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Before he died that night, in October 1998, Kevin Cerbelli called his mother from his basement apartment in Queens, accusing her of secretly feeding him egg yolks in his breakfast. He told her someone in the park was spiking his cigarettes with drugs, and called himself the devil's twin. She had been through this with him before, and she begged him to go to the hospital, or at least to bed. Things will look better in the morning, she told him. But he dropped the receiver and walked away. She thought she heard his footfalls as he climbed the stairs.", "headline": {"main": "When Mental Illness Meets Police Firepower; Shift in Training for Officers Reflects Lessons of Encounters Gone Awry"}, "abstract": "Incidents in which New York City police have killed emotionally disturbed persons (EDP) have led to lawsuits against city and raised questions about adequacy of training police receive to handle such cases and equipment at their disposal; some critics call for changes in patrol guide or formation of special EDP response teams; police note that they respond to 70,000 EDP calls each year, that vast majority are are without incident and that they need to protect themselves from harm; photo (L)", "print_page": "27", "word_count": 2013, "_id": "4fd24bb98eb7c8105d7ead31", "snippet": "Before he died that night, in October 1998, Kevin Cerbelli called his mother from his basement apartment in Queens, accusing her of secretly feeding him egg yolks in his breakfast. He told her someone in the park was spiking his cigarettes with...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/28/nyregion/when-mental-illness-meets-police-firepower-shift-training-for-officers-reflects.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "subject", "value": "POLICE BRUTALITY AND MISCONDUCT"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "POLICE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michael", "lastname": "WILSON"}], "original": "By MICHAEL WILSON"}, "document_type": "article", "pub_date": "2003-12-28T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Bush administration is proposing a new policy that would punish hospitals, drugstores and other health care providers that charge Medicare or Medicaid substantially more than their usual charges to private insurers. Violators could be excluded from participation in any federal health care program, a severe penalty that is being bitterly fought by the health care industry.", "headline": {"main": "Some Health Care Providers May Face Payment Penalty"}, "abstract": "Bush administration proposes penalties for hospitals, drugstores and other health care providers that charge Medicare and Medicaid substantially more than their usual charges to private insurers; violators could be excluded from participation in any federal health care program, severe penalty that is being bitterly fought by health care industry; employers and private health plans have in many cases negotiated deep discounts, using their market power to obtain bargains not available to Medicare (M)", "print_page": "24", "word_count": 1043, "_id": "4fd249178eb7c8105d7e6373", "snippet": "The Bush administration is proposing a new policy that would punish hospitals, drugstores and other health care providers that charge Medicare or Medicaid substantially more than their usual charges to private insurers.    Violators could be excluded...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/28/us/some-health-care-providers-may-face-payment-penalty.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-12-28T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "At 2 that cool winter morning last year when news trickled in that Dr. Reddy's Laboratories had successfully challenged the patent on a blockbuster hypertension drug in a New Jersey court, jubilant senior executives uncorked a bottle of Champagne. By daybreak, however, the celebration at Dr. Reddy's, a leading Indian drug maker based in Hyderabad, had come to an abrupt end. The patent holder, Pfizer Inc., loath to give up rights to the drug, Norvasc, with its worldwide sales of $3.8 billion last year, had announced that it would take the challenge to a higher court.", "headline": {"main": "Generic Drugs From India Prompting Turf Battles", "kicker": "INTERNATIONAL BUSINESS"}, "abstract": "Dr Reddy's Laboratories, Ranbaxy Laboratories and other Indian manufacturers of generic drugs are aggressively challenging patents held by world's largest pharmaceutical companies in bid to expand in $17 billion US generics market; can produce drugs at fraction of what it costs to make them in West and are generating much higher margins in US by being among earliest to enter market when patents expire; are meeting fierce resistance in courts from patent holders, who argue that generics will whittle away incentive to innovate, jeopardize investment in new and much-needed drugs and sacrifice consumer safety; patent holders are also patenting component chemicals and processes in addition to drug itself; photos (M)", "print_page": "1", "word_count": 1597, "_id": "4fd27a9e8eb7c8105d83ed8d", "snippet": "At 2 that cool winter morning last year when news trickled in that Dr. Reddy's Laboratories had successfully challenged the patent on a blockbuster hypertension drug in a New Jersey court, jubilant senior executives uncorked a bottle of Champagne.   ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/26/business/international-business-generic-drugs-from-india-prompting-turf-battles.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "INDIA"}, {"name": "organizations", "value": "RANBAXY LABORATORIES"}, {"name": "organizations", "value": "DR REDDY'S LABORATORIES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "INVENTIONS AND PATENTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Saritha", "lastname": "RAI"}], "original": "By SARITHA RAI"}, "document_type": "article", "pub_date": "2003-12-26T00:00:00Z", "section_name": "Technology; Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Two provisions buried deep in the nearly 700-page Medicare drug law may limit the discounts that insurers and pharmacy benefit managers can get from drug makers -- and, therefore, how far the new drug benefit for the elderly will stretch, executives say. One provision allows doctors to prescribe for their Medicare patients whatever drug they deem ''medically necessary,'' even if that drug is not on an insurer's list of preferred drugs. Other language in the measure, which President Bush signed into law on Dec. 8, requires that companies providing a drug benefit make at least two comparable drugs available in every treatment category.", "headline": {"main": "Medicare Law Might Limit Drug Discounts For Insurers"}, "abstract": "Provisions buried deep in Medicare drug law may limit discounts that insurers and pharmacy benefit managers can get from drug makers and, as a result, how far new drug benefit for elderly will stretch; one provision allows doctors to prescribe for their Medicare patients whatever drug they deem 'medically necessary,' even if that drug is not on insurer's list of preferred drugs; other language in measure requires that companies providing drug benefit make at least two comparable drugs available in every treatment category (M)", "print_page": "1", "word_count": 993, "_id": "4fd27a9f8eb7c8105d83eeaf", "snippet": "Two provisions buried deep in the nearly 700-page Medicare drug law may limit the discounts that insurers and pharmacy benefit managers can get from drug makers -- and, therefore, how far the new drug benefit for the elderly will stretch, executives...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/24/business/medicare-law-might-limit-drug-discounts-for-insurers.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-12-24T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 4, "offset": 0, "time": 58}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}